30652-11-0 Usage
Description
Deferiprone, the first oral iron chelator, was marketed in India for the
management of thalassaemia. Patients with thalassaemia, a blood related genetic
disorder, require life time transfusion which causes excessive deposition of iron in liver
and spleen, subsequent damage to organs and eventually death unless iron is removed
by a chelator. Deferiprone is a potent iron chelator that mobilizes excessive iron from
iron storage proteins ferritin and hemosiderin, from iron saturated transferrin and
lactoferrin, but not from hemoglobin. The deferiprone-iron complex is excreted in urine
and bile. Deferiprone was reportedly well accepted by patients and no hematological
toxicity was observed. Deferiprone has also been demonstrated as an effective and
safe chelator in the mobilization of aluminum.
Chemical Properties
White Needles
Originator
Cipla (India)
Uses
Different sources of media describe the Uses of 30652-11-0 differently. You can refer to the following data:
1. 3-Hydroxy-1,2-dimethyl-4(1H)-pyridone (OH-pyridone) may be used in the bacterial killing assays. It has been employed as hydroxyketone chelating agent and its cytotoxic action against oral human normal and tumor cell lines has been evaluated.
2. iron chelating agent
3. A chelator that could replace disferrioxamine. It is orally and parenterally effective in the removal of iron in vivo from rabbits and mice and also from transferrin and ferritin in vitro
Definition
ChEBI: A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.
Brand name
Kelfer
General Description
3-Hydroxy-1,2-dimethyl-4(1H)-pyridone (Hdpp, Deferiprone) is a hydroxy ketone derivative. It reacts with uranyl salts [UO2(NO3)2] in aqueous acidic solution to afford mono nuclear complexes ([UO2(dpp)(Hdpp)2(H2O)]ClO4). X-ray studies have been conducted to examine the structure and geometry of these complexes.
Clinical Use
Orally administered chelator:Treatment of transfusional iron overload
Drug interactions
Potentially hazardous interactions with other drugsNone known.
Metabolism
Deferiprone is hepatically metabolised to an inactive
glucuronide metabolite and is excreted mainly in the urine
as the metabolite and the iron-deferiprone complex, with
a small amount of unchanged drug.
References
1) Hider and Hoffbrand (2018),?The Role of Deferiprone in Iron Chelation; N. Engl. J. Med.,?379?2140
2) Sripetchwandee?et al.?(2016),?A combination of an iron chelator with an antioxidant effectively diminishes the dendritic loss, tau-hyperphosphorylation, amyloid-β accumulation and brain mitochondrial dynamic disruption in rats with chronic iron-overload., Neuroscience?332?191
3) Liu?et al.?(2018),?Iron and Alzheimer’s Disease: From Pathogenesis to Therapeutic Implications;?Front. Neurosci,?12?632
Check Digit Verification of cas no
The CAS Registry Mumber 30652-11-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,0,6,5 and 2 respectively; the second part has 2 digits, 1 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 30652-11:
(7*3)+(6*0)+(5*6)+(4*5)+(3*2)+(2*1)+(1*1)=80
80 % 10 = 0
So 30652-11-0 is a valid CAS Registry Number.
InChI:InChI=1/C7H9NO2/c1-5-6(9)3-4-8(2)7(5)10/h3-4,10H,1-2H3